The Alzheimer’s Drug Discovery Foundation (ADDF) through its Diagnostics Accelerator (DxA) and the Alzheimer’s Disease Data Initiative (ADDI), have a new partnership which will facilitate the sharing of Alzheimer’s research data through the ADDI’s data sharing and analysis platform, the AD Workbench. The aim of this partnership is to encourage and enable ADDF-funded researchers to leverage the AD Workbench to fast-track the development of new and novel diagnostics and biomarkers by providing broader access to large datasets.
Technology-based diagnostics companies regularly generate large amounts of data to develop biomarkers. Often, this data is only utilized for a singular purpose, but there is the potential to repurpose these large datasets to analyze and measure multiple metrics. By enabling access to these datasets, the AD Workbench will reduce redundancy, slow the collection of unused data, and decrease the number of patient participants needed to glean statistically significant insights.
“The ADDF firmly believes that timely disease intervention requires an early and accurate Alzheimer’s diagnosis, which was the impetus for the Diagnostics Accelerator,” says Howard Fillit, MD, Co-Founder and Chief Science Officer at the ADDF. “This partnership will build on the robust diagnostics portfolio the accelerator has built by offering new ways to streamline biomarker development and commercialization, which is crucial for developing the next generation of Alzheimer’s therapeutics.”
“Providing a platform to store and share big data on Alzheimer’s diagnostics research presents great opportunities for researchers to work together and repurpose data to uncover more valuable insights from it,” notes Tetsuyuki Maruyama, PhD, Executive Director at the ADDI. “This initiative will help democratize the data now being generated from breakthrough research, which we expect will fuel the next wave of important new findings.”
For more information about the Alzheimer’s Drug Discover Foundation, please see: https://www.alzdiscovery.org
For more information about the Diagnostics Accelerator, please see: https://alzdiscovery.org/research-and-grants/diagnostics-accelerator